UC San Diego Health, the region’s only academic medical center, delivers world-class care and translates groundbreaking research into promising new treatments for patients.
Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.
UC San Diego Health has been recognized among the nation’s best hospitals for 2019-20 by U.S. News & World Report. The annual “Best Hospitals” rankings are designed to assist patients and their doctors in making informed decisions about where to receive care for challenging health conditions.
The California governor’s office today announced a statewide expansion to make CA Notify available to all Californians starting Thursday, December 10 in partnership with UC San Diego Health.
UC San Diego Health is the first hospital on the West Coast to perform heart transplant surgery from a donor after circulatory death using a new portable organ care system. The investigational procedure could significantly decrease transplant waiting list times and improve patient outcomes.
UC San Diego Health announces it has been recognized as a top performer in the 2021 Bernard A. Birnbaum, MD, Quality Leadership Annual Ranking by Vizient Inc.
UC San Diego Health hospitals in Hillcrest and La Jolla have received grades of ‘A’ for excellence in safety and quality for the Fall 2019 Leapfrog Hospital Safety Grade report.
Becker's Hospital Review, September 24
Becker's Clinical Leadership, September 28
STAT News, September 29
FOX 5/KUSI, September 30
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
